Aptamer-functionalized triptolide with release controllability as a promising targeted therapy against triple-negative breast cancer.
Chen Y, Yang J, Wang C, Wang T, Zeng Y, Li X, Zuo Y, Chen H, Zhang C, Cao Y, Sun C, Wang M, Cao X, Ge X, Liu Y, Zhang G, Deng Y, Peng C, Lu A, Lu J.
Chen Y, et al. Among authors: li x.
J Exp Clin Cancer Res. 2024 Jul 25;43(1):207. doi: 10.1186/s13046-024-03133-5.
J Exp Clin Cancer Res. 2024.
PMID: 39054545
Free PMC article.